Roche adapts newer breast cancer drug in face of Herceptin imitations
By John Miller ZURICH (Reuters) – Swiss drugmaker Roche aims to broaden the use of its...
Read MoreFeb 5, 2019
By John Miller ZURICH (Reuters) – Swiss drugmaker Roche aims to broaden the use of its...
Read MoreFeb 5, 2019
CalproQuest survey may increase pretest probability for a positive calprotectin test
Read MoreFeb 5, 2019
Asian and black patients younger at diagnosis, have lower cognitive scores than white patients
Read MoreFeb 5, 2019
Variance not fully explained by differences in access to health care providers or patient characteristics
Read MoreFeb 5, 2019
At one month, no significant difference seen in positive outcomes for treatment vs. control
Read MoreFeb 5, 2019
Substantial, conclusive evidence of therapeutic efficacy found for 85.5 percent of qualifying conditions
Read MoreFeb 5, 2019
Influenza row modified to reflect current recommendations for live attenuated flu vaccine
Read MoreFeb 5, 2019
Slightly but not significantly increased risks seen in children conceived by ICSI or cryopreservation
Read MoreFeb 5, 2019
Autologous breast reconstruction associated with improved patient satisfaction, quality of life
Read MoreFeb 5, 2019
Known factors explain 65.3 percent of excess SCD risk in African-Americans, especially women
Read MoreFeb 5, 2019
Odds of meeting all three recommendations vary by age, race/ethnicity, BMI, marijuana use
Read MoreFeb 5, 2019
No evidence seen for benefits of pancreatic cancer screening, treatment of screen-detected cancer
Read MoreFeb 5, 2019
IPV victims underwent more imaging studies in preceding five years than controls
Read MoreFeb 5, 2019
Protocol that specifies how often to assess dry weight tied to lower all-cause, CVD mortality
Read MoreFeb 5, 2019
Estimated difference in test scores 0.45 after adjustment for variables such as socioeconomic status
Read MoreFeb 5, 2019
Doctors who violate the proposed law could be disciplined by the state’s medical board
Read MoreFeb 4, 2019
By Tina Bellon (Reuters) – Johnson & Johnson’s DePuy Orthopaedics unit is in...
Read MoreFeb 4, 2019
WASHINGTON (Reuters) – A powerful U.S. Senate committee on Monday invited seven...
Read MoreFeb 4, 2019
By Lisa Rapaport (Reuters Health) – Compounded pain creams are no better for chronic pain than topical treatments that contain no medicine at all, a U.S. study suggests. Compounded medicines are custom-blended by...
Read MoreFeb 4, 2019
By Yasmeen Abutaleb WASHINGTON (Reuters) – U.S. Senator Bernie Sanders sent a letter to...
Read More